title: Human papillomavirus vaccination: current indications and future directions.
abstract: Human papillomavirus (HPV) is one of the most common sexually transmitted infections affecting both men and women worldwide. The development of the prophylactic HPV vaccines is a significant pharmaceutical innovation with potential to reduce HPV-related morbidity. However, barriers to the universal use and acceptability of the HPV vaccines continue to exist in both economically privileged and disadvantaged countries. It may be decades before the impact of preventive vaccines on HPV-related diseases caused by the considerable burden of HPV infections will be seen. Collaborative efforts must continue to promote vaccine implementation.
authors.affiliation: Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
authors.forename: Leda
authors.initials: L
authors.lastname: Gattoc
authors.forename: Navya
authors.initials: N
authors.lastname: Nair
authors.forename: Kevin
authors.initials: K
authors.lastname: Ault
mesh_terms: D000293:Adolescent; D000328:Adult; D001005:Anus Neoplasms / Q000517:prevention & control / Q000821:virology; D002648:Child; D003218:Condylomata Acuminata / Q000821:virology; D005260:Female; D052162:Human papillomavirus 16; D052161:Human papillomavirus 18; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000639:trends; D008875:Middle Aged; D009959:Oropharyngeal Neoplasms / Q000821:virology; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D053918:Papillomavirus Vaccines; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D012749:Sexually Transmitted Diseases; D002578:Uterine Cervical Dysplasia / Q000821:virology; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D014626:Vaginal Smears; D014846:Vulvar Neoplasms / Q000821:virology; D055815:Young Adult
chemical_list: D053918:Papillomavirus Vaccines